Search
Anteris Technologies Global Corp
AVRAdd to Watchlist
9.610USD
-0.170-1.74%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
934.40MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of Anteris Technologies Global Corp is 8.00, ranking 66 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 17.50, with a high of 22.00 and a low of 9.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
14.750
Target Price
+50.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Anteris Technologies Global Corp
AVR
4
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Anteris Technologies Global Corp's expected revenue for the next quarter?
Anteris Technologies Global Corp's expected revenue is 1.50M.
What is Anteris Technologies Global Corp's price target?
Analysts forecast that Anteris Technologies Global Corp's price target is USD 17.50, with the highest forecast at USD 22.00 and the lowest forecast at USD 9.00.
How have Anteris Technologies Global CorpAVR's recent earnings per share performed?
The market expectation was USD -0.28, while Anteris Technologies Global CorpAVR's earnings per share (EPS) for the previous quarter was USD -0.74. EPS for the next quarter is expected at USD -0.21.
What is the analyst rating for Anteris Technologies Global Corp?
Based on the ratings of Anteris Technologies Global Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
